A case of primary immunoglobulin light chain amyloidosis with a delayed appearance of Bence Jones protein in urine

Nephrology

Volumn 9, Issue 3, 2004, Pages 122-125

  Kurusu, Atsushi ^a   Yamada, Toshiyuki ^b   Yamaji, Kenji ^a   Nishitani, Miho ^a   Tashiro, Kyoichi ^a   Maeda, Kunimi ^a   Horikoshi, Satoshi ^a   Shirato, Isao ^a   Rinno, Hisaki ^c   Tomino, Yasuhiko ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

^c JUNTENDO UNIVERSITY URAYASU HOSPITAL   (Japan)

Author keywords

Bence Jones protein; Immunoglobulin light chain amyloidosis; Myeloma

Indexed keywords

AMYLOID A PROTEIN; BENCE JONES PROTEIN; CONGO RED; IMMUNOGLOBULIN LIGHT CHAIN; MANGANESE DERIVATIVE; PERMANGANATE; PROTEIN PRECURSOR; UNCLASSIFIED DRUG;

ADULT; AMYLOIDOSIS; ARTICLE; BONE MARROW; CASE REPORT; CELL PROLIFERATION; DIAGNOSTIC ACCURACY; DIGESTION; DUODENUM BIOPSY; FIBER; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; IMMUNOELECTROPHORESIS; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; MALE; NEPHROTIC SYNDROME; OXIDATION; PLASMA CELL; PRIORITY JOURNAL; PROTEINURIA; URINE;

AMYLOIDOSIS; BENCE JONES PROTEIN; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; MALE; MIDDLE AGED; TIME FACTORS;

EID: 3042836713     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2004.00246.x     Document Type: Article

References (9)

1. Hoshii Y, Setoguchi M, Iwata T et al. Useful polyclonal antibodies against synthetic peptides corresponding to immunoglobulin light chain constant region for immunohistochemical detection of immunoglobulin light chain amyloidosis. Pathol. Int. 2001; 51: 264-70.
2. Goddard IR, Jackson R, Jones JM. AL Amyloidosis: Therapeutic response in two patients with renal involvement. Nephrol. Dial. Transplant. 1991; 6: 592-4.
3. Wright JR, Calkins E, Humphrey RL. Potassium permanganate reaction in amyloidosis. A histologic method to assist in differentiating forms of this disease. Lab. Invest. 1977; 36: 274-81.
4. Ronco PM, Aucouturier P, Moulin B. Renal amyloidosis and glomerular disease with monoclonal immunogloblin deposition. In: Johnson RJ, Feehally J, eds. Comprehensive Clinical Nephrology. London: Mosby, 2000; 31.1-7.
5. Falk RH, Comenzo RL, Skinner M. The systemic amyloidoses. N. Engl. J. Med. 1997; 338: 898-909.
6. Kyle RA. Multiple myeloma and other plasma cell disorders. In: Hoffman R, Benze Jr EJ, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, eds. Hematology: Basic Principles and Practice, 2nd ed. New York: Churchill Livingstone, 1995; 1354-74.
7. Ayabe T, Maekawa I, Ashida T, Taruishi M, Shibata Y, Namiki M. A case of gastric amyloidosis developing into Bence Jones type multiple myeloma, treated effectively by cyclo-VAMP chemotherapy. Gan To Kagaku Ryoho 1993; 20: 2399-403 (in Japanese).
8. Gaikwad S, Varthakavi P, Chandalia M, Nihalani KD. Macroglossia presenting features of primary amyloidosis. J. Assoc. Physicians India 1993; 41: 386-8.
9. Raikumar SV, Gertz MA, Kyle RA. Primary systemic amyloidosis with delayed progression to multiple myeloma. Cancer 1998; 82: 1501-5.